Trans Genic Inc. (2342) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Kidswell Bio Corp.

OncoTherapy Science, Inc.

Cyfuse Biomedical KK

MEDINET Co., Ltd.

SUSMED, Inc.

Stella Pharma Corp.

Trans Genic Inc.

Oncolys BioPharma, Inc.

Chiome Bioscience, Inc.

StemCell Institute

Carna Biosciences, Inc.

Why is Trans Genic Inc. ?

Poor long term growth as Operating profit has grown by an annual rate -181.00% of over the last 5 years

Negative results in Jun 25

NET PROFIT(HY) At JPY -427.51 MM has Grown at -9,252.58%
ROCE(HY) Lowest at -18.29%
DEBT-EQUITY RATIO (HY) Highest at 11.41 %

Risky - Negative Operating Profits

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 38.78%, its profits have fallen by -114.9%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Trans Genic Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Trans Genic Inc.

38.78%

0.18

93.99%

Japan Nikkei 225

28.54%

1.11

25.75%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

5.32%

EBIT Growth (5y)

-181.00%

EBIT to Interest (avg)

21.33

Debt to EBITDA (avg)

Net Debt to Equity (avg)

0.05

Sales to Capital Employed (avg)

1.55

Tax Ratio

61.33%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

14.69%

ROE (avg)

9.76%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.47

EV to EBIT

-34.46

EV to EBITDA

30.22

EV to Capital Employed

0.50

EV to Sales

0.22

PEG Ratio

Dividend Yield

ROCE (Latest)

-1.44%

ROE (Latest)

-3.42%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

No Trend

Mildly Bullish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company

PRE-TAX PROFIT(Q)

At JPY 60.64 MM has Grown at 180.22%

NET PROFIT(Q)

At JPY 31.79 MM has Grown at 123.9%

RAW MATERIAL COST(Y)

Fallen by -10.25% (YoY

OPERATING PROFIT(Q)

Highest at JPY 82.61 MM

OPERATING PROFIT MARGIN(Q)

Highest at 2.58 %

EPS(Q)

Highest at JPY 1.62

-17What is not working for the Company

NET PROFIT(HY)

At JPY -427.51 MM has Grown at -9,252.58%

ROCE(HY)

Lowest at -18.29%

DEBT-EQUITY RATIO (HY)

Highest at 11.41 %

INTEREST(Q)

Highest at JPY 12.9 MM

Here's what is working for Trans Genic Inc.

Pre-Tax Profit

At JPY 60.64 MM has Grown at 180.22%

over average net sales of the previous four periods of JPY -75.59 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (JPY MM)

Net Profit

At JPY 31.79 MM has Grown at 123.9%

over average net sales of the previous four periods of JPY -133.04 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (JPY MM)

Operating Profit

Highest at JPY 82.61 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (JPY MM)

Operating Profit Margin

Highest at 2.58 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at JPY 60.64 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (JPY MM)

EPS

Highest at JPY 1.62

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (JPY)

Raw Material Cost

Fallen by -10.25% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Trans Genic Inc.

Interest

At JPY 12.9 MM has Grown at 36.83%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Interest

Highest at JPY 12.9 MM

in the last five periods and Increased by 36.83% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Debt-Equity Ratio

Highest at 11.41 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio